Search for: "Pharmaceutical Associates, Inc."
Results 761 - 780
of 1,892
Sort by Relevance
|
Sort by Date
2 Apr 2013, 10:33 am
George Yu, an experienced patent litigation lawyer at Schiff Hardin LLP on the legality of reverse payment settlements in the pharmaceutical sector- a strategy wherein a patent holder pays a generic pharmaceutical manufacturer to delay or withdraw any challenges to patent validity. [read post]
1 Apr 2013, 8:29 am
” Upon receiving this reissue patent, Pfizer immediately filed a lawsuit against Teva Pharmaceuticals USA, Inc.; Mylan Pharmaceuticals Inc.; Watson Laboratories, Inc.; Lupin Pharmaceuticals, USA, Inc.; Apotex Corp.; and Apotex, Inc. in the United States District Court for the Eastern District of Virginia for infringement of the reissue patent. [read post]
25 Mar 2013, 1:29 pm
Food and Drug Administration is alerting health care providers and patients of a voluntary nationwide recall of all lots of Omontys Injection by Affymax, Inc., of Palo Alto, Calif., and Takeda Pharmaceuticals Company Limited, of Deerfield, Ill. [read post]
19 Mar 2013, 6:00 am
Wolpert, Director of Marketing at Ringler Associates, offered some insights. [read post]
18 Mar 2013, 10:55 am
Google Inc. [read post]
15 Mar 2013, 6:00 am
“Wholesale pharmacies who contract with physicians to provide pharmaceuticals to them on a consignment basis for dispensing to their workers compensation patients, cannot seek payment for the pharmaceuticals directly from the employer/insurer underRebel Distributors Corp., Inc. d/b/a Physician Partner and Pharmacy Partner v. [read post]
15 Mar 2013, 4:41 am
In association with Bloomberg Law [read post]
12 Mar 2013, 6:47 am
” In association with Bloomberg Law [read post]
11 Mar 2013, 9:05 am
In association with Bloomberg Law [read post]
10 Mar 2013, 9:59 pm
Searle LLC; Pfizer Asia Pacific PTE, LTD.; • Defendants: Lupin Pharmaceuticals, Inc.; Teva Pharmaceuticals USA, Inc.; Mylan Pharmaceuticals Inc.; Watson Laboratories, Inc.; Apotex Inc.; Apotex Corp. [read post]
6 Mar 2013, 4:30 am
Depuy Motech, Inc., 61 F. [read post]
5 Mar 2013, 1:56 am
On March 5, the Department of Justice announced that generic drug maker Par Pharmaceuticals, Inc., entered a guilty plea and agreed to pay a combined $45 million to settle criminal and civil charges that it promoted Megace ES off-label. [read post]
4 Mar 2013, 4:02 pm
Takeda Pharmaceuticals America Inc., CGC-12-518535, California Superior Court (Los Angeles) [read post]
3 Mar 2013, 8:42 pm
Subsequently, I wrote about the draft policy proposal issued by Department of Pharmaceuticals (DOP) on price negotiation of patented drugs. [read post]
3 Mar 2013, 2:51 pm
Below, he provides his thoughts on the true stakes in Association for Molecular Pathology v. [read post]
26 Feb 2013, 9:02 am
stubid=20311 Testimonials: "Excellent overviews of AIA from those who wrote it, those who will implement it, and those who must live with it" - Graham Douglas, IDDEX (2012) "Assessments and points of view you won't find any place else" - Jim Farmer, Georgetown University (2012) You will network with: Accuray Inc, Americas Bankers Association, Boeing Company, CIENA, Department of Homeland Security, Eldelman, El Cap Ventures, Eli Lilly & Company, Embassy of Canada,… [read post]
23 Feb 2013, 11:37 am
Takeda Pharmaceuticals America, Inc., CGC-12-518535, California Superior Court (Los Angeles). [read post]
20 Feb 2013, 6:00 am
©2013 Amaxx Risk Solutions, Inc. [read post]
16 Feb 2013, 7:23 am
Merrell Dow Pharmaceuticals, Inc., 509, U.S. 579 (1993). [read post]
12 Feb 2013, 12:22 pm
., Inc., No. 1:2008-cv-04119 (S.D.N.Y., Feb. 5, 2013). [read post]
